These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 37143440

  • 1. NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS.
    Zito Marino F, Buono S, Montella M, Giannatiempo R, Messina F, Casaretta G, Arpino G, Vita G, Fiorentino F, Insabato L, Sgambato A, Orditura M, Franco R, Accardo M.
    J Pathol Clin Res; 2023 Sep; 9(5):367-377. PubMed ID: 37143440
    [Abstract] [Full Text] [Related]

  • 2. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and detection methodology for preliminary exploration of NTRK fusion in gastric cancer from a single-center retrospective cohort.
    Dong K, Yin L, Wang Y, Jia L, Diao X, Huang X, Zhou L, Lin D, Sun Y.
    Hum Pathol; 2024 Jun; 148():87-92. PubMed ID: 38653403
    [Abstract] [Full Text] [Related]

  • 4. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A, Mansukhani MM, Fernandes H, Hsiao SJ.
    Cancer Genet; 2022 Apr; 262-263():47-52. PubMed ID: 35007853
    [Abstract] [Full Text] [Related]

  • 5. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
    Zhao R, Yao F, Xiang C, Zhao J, Shang Z, Guo L, Ding W, Ma S, Yu A, Shao J, Zhu L, Han Y.
    J Pathol Clin Res; 2021 Jul; 7(4):375-384. PubMed ID: 33768710
    [Abstract] [Full Text] [Related]

  • 6. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma.
    Wu S, Shi X, Ren X, Li K, Pang J, Liang Z.
    Front Mol Biosci; 2021 Nov; 8():654387. PubMed ID: 34490345
    [Abstract] [Full Text] [Related]

  • 8. Feasibility of two-step approach for screening NTRK fusion in two major subtypes of non-small cell lung cancer within a large cohort.
    Dong K, Zhu Y, Liu X, Sun W, Yang X, Chi K, Jia L, Diao X, Huang X, Zhou L, Lin D.
    Hum Pathol; 2024 Jul; 149():39-47. PubMed ID: 38866255
    [Abstract] [Full Text] [Related]

  • 9. NTRK Gene Fusion Detection in Atypical Spitz Tumors.
    Cappellesso R, Nozzoli F, Zito Marino F, Simi S, Castiglione F, De Giorgi V, Cota C, Senetta R, Scognamiglio G, Anniciello AM, Cesinaro AM, Mandalà M, Gianatti A, Valente MG, Valeri B, Sementa AR, Ricci C, Corti B, Roviello G, Dei Tos AP, Franco R, Massi D.
    Int J Mol Sci; 2021 Nov 15; 22(22):. PubMed ID: 34830218
    [Abstract] [Full Text] [Related]

  • 10. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
    Endocr Pathol; 2020 Dec 15; 31(4):348-358. PubMed ID: 32880785
    [Abstract] [Full Text] [Related]

  • 11. Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer.
    Schraa SJ, Stelloo E, Laclé MM, Swennenhuis JF, Brosens LAA, Fijneman RJA, Feitsma H, Koopman M, de Leng WW, Vink GR, Bol GM.
    Virchows Arch; 2023 Jun 15; 482(6):983-992. PubMed ID: 37067589
    [Abstract] [Full Text] [Related]

  • 12. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
    Marchiò C, Scaltriti M, Ladanyi M, Iafrate AJ, Bibeau F, Dietel M, Hechtman JF, Troiani T, López-Rios F, Douillard JY, Andrè F, Reis-Filho JS.
    Ann Oncol; 2019 Sep 01; 30(9):1417-1427. PubMed ID: 31268127
    [Abstract] [Full Text] [Related]

  • 13. The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.
    Hondelink LM, Schrader AMR, Asri Aghmuni G, Solleveld-Westerink N, Cleton-Jansen AM, van Egmond D, Boot A, Ouahoud S, Khalifa MN, Wai Lam S, Morreau H, Bovee JVMG, van Wezel T, Cohen D.
    Eur J Cancer; 2022 Sep 01; 173():229-237. PubMed ID: 35933886
    [Abstract] [Full Text] [Related]

  • 14. The Diagnostic Value of Pan-Trk Expression to Detect Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion in CNS Tumours: A Study Using Next-Generation Sequencing Platform.
    Mohamed F, Kurdi M, Baeesa S, Sabbagh AJ, Hakamy S, Maghrabi Y, Alshedokhi M, Dallol A, Halawa TF, Najjar AA, Fdl-Elmula I.
    Pathol Oncol Res; 2022 Sep 01; 28():1610233. PubMed ID: 35295612
    [Abstract] [Full Text] [Related]

  • 15. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S, Liu Y, Shi X, Zhou W, Zeng X.
    Dig Liver Dis; 2023 Dec 01; 55(12):1757-1764. PubMed ID: 37142453
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancer.
    Dyrbekk APH, Warsame AA, Suhrke P, Ludahl MO, Zecic N, Moe JO, Lund-Iversen M, Brustugun OT.
    Clin Exp Med; 2024 Jan 19; 24(1):10. PubMed ID: 38240952
    [Abstract] [Full Text] [Related]

  • 17. MLH1/PMS2 Expression Could Tell Classical NTRK Fusion in Fluorescence In Situ Hybridization Positive Colorectal Carcinomas.
    Fu Y, Li Z, Gao F, Yang J, Wu H, Zhang B, Pu X, Fan X.
    Front Oncol; 2021 Jan 19; 11():669197. PubMed ID: 33996597
    [Abstract] [Full Text] [Related]

  • 18. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL.
    Am J Surg Pathol; 2018 Jul 19; 42(7):927-935. PubMed ID: 29683818
    [Abstract] [Full Text] [Related]

  • 19. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR.
    Am J Surg Pathol; 2018 Jun 19; 42(6):791-798. PubMed ID: 29553955
    [Abstract] [Full Text] [Related]

  • 20. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B.
    Mod Pathol; 2021 Feb 19; 34(2):396-407. PubMed ID: 32860002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.